Community Academic Profiles

Jared Tinklenberg

Publication Details

  • Rate of cognitive decline in AD is accelerated by the interleukin-1 alpha -889 *1 allele.

    Murphy GM, Claassen JD, DeVoss JJ, Pascoe N, Taylor J, Tinklenberg JR, Yesavage JA. Neurology. 2001; 56 (11): 1595-7

    The reason for differences in rate of cognitive decline in AD is unknown. The interleukin-1 alpha (IL-1 alpha) -889 *2 allele is associated with increased risk for AD. Surprisingly, in a sample of 114 patients followed for an average of 3.8 years, individuals homozygous for the IL-1 alpha -889 *1 allele declined significantly more rapidly on the Mini-Mental State Examination than did others. There was no difference in rate of decline between patients with and without the APOE epsilon 4 allele. These results support the hypothesis that inflammation is important in the clinical course of AD.

    PubMedID: 11402127

Stanford Medicine Resources:

Footer Links: